![](/images/7e003421-9665-4663-89b3-b7931db87b74/ws/camurus-hero-2.jpg)
Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
updates
Latest news
Change in number of shares and votes in Camurus
New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl
Camurus submits its first UN Global Compact Communication on Progress and renews the Nasdaq Transparency Partner certificate
![](/images/25a692c7-edb6-45bc-942d-9fe7c9202cf6/ta/iStock-497220040_high.jpg)
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
16 Jul
Interim Report January-June 2024
The interim report January-June is published on 16 July 2024.
-
16 Jul
Interim Report January-June 2024 – Audiocast
Financial analysts and media are invited to attend a telephone conference and presentation of the second quarter results at 2.00 pm CET. Audiocast
-
21 Aug
SEB Nordic Large Cap Seminar
Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 21 August, at 12.50 CEST. The presentation can be seen by the conference participants.
![](/images/ed340657-7552-4dd0-a89d-fcf2c1066e26/ta/Q2A1693_high.jpg)
Latest financial report
Camurus’ Interim Report January-March 2024
8 May 2024
Annual General Meeting
Camurus’ Annual General Meeting 2024 was held on Wednesday, 8 May 2024 at Elite Hotel Ideon in Lund, Sweden.
See documents for Annual General Meeting 2024
See resolutions at the Annual General Meeting 2024
See more information on Camurus' general meetings
![](/images/5c6f5390-bb25-4ed4-b15f-6bf17c7d60f8/ta/Pipeline_insert_2_2000x1333.jpg)
Pipeline
Diversified pipeline with large potential
Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
![](/images/76b061e0-843c-42d7-8f2d-2e9488a5b9a3/ta/Sustainability_2500x1408px.jpg)